Lascufloxacin hydrochloride is a synthetic fluoroquinolone antibacterial API developed mainly for the treatment of respiratory tract infections. It was developed by Kyorin Pharmaceutical Co., Ltd. and is marketed in Japan under the brand Lasvic®. It is grouped under the following drug class(es): Fluoroquinolones, Quinolones and Topoisomerase inhibitors. Its therapeutic use is listed as anti-infectives, antibacterials and antibiotics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Lascufloxacin HCl and Lasvic. Its PubChem CID is 71528767.
Lascufloxacin hydrochloride
| CAS No | 1433857-09-0 |
|---|---|
| Molecular Formula | C21H25ClF3N3O4 |
| Molecular Weight | 475.9 g/mol |
| Synonyms | 7-[(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidin-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lascufloxacin hydrochloride is a synthetic fluoroquinolone antibacterial API developed mainly for the treatment of respiratory tract infections. , Ltd. and is marketed in Japan under the brand Lasvic®.
The listed CAS number is 1433857-09-0.
The listed molecular formula is C21H25ClF3N3O4.
The listed molecular weight is 475.9 g/mol.
7-[(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidin-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride.
The source lists Lascufloxacin HCl and Lasvic.